Quantum technology gains traction in finance and life sciences

Quantum computing companies experienced a market dip, prompting investment analysis that highlighted IonQ as a top buy due to its trapped‑ion approach and 99.99% two‑qubit gate fidelity, while Rigetti Computing was identified as a sell because of lower accuracy and high cooling costs. The analysis noted IonQ’s vertical integration strategy, including its acquisition of quantum foundry SkyWater.

Separately, a Capgemini research report underscored the growing adoption of quantum technologies in the life sciences, with one‑in‑five firms already running pilots. Potential uses include quantum‑enhanced drug‑molecule simulation, optimization of candidate design and manufacturing, and quantum sensors for biomedical imaging. The report also warned of the need for post‑quantum encryption to protect clinical data and positioned Capgemini’s Quantum Lab as a partner for organizations seeking quantum expertise.